Back to search
Amyotrophic Lateral Sclerosis (Healthy Volunteers)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Amyotrophic Lateral Sclerosis (Healthy Volunteers) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Amyotrophic Lateral Sclerosis (Healthy Volunteers) trials you may qualify forThe primary purpose of this study is to evaluate the safety and tolerability of prosetin in healthy volunteers and participants with ALS.
The primary objectives of this study are to investigate the safety and tolerability of VRG50635 and to determine how VRG50635 is absorbed by the body.
The first-in-human Phase 1 study described herein will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SPG302 in healthy volunteers…